Company intelligence / Profile preview

Max Neeman International

Delhi, Delhi, India

Ownership: Private
Employees: ~292
Development stage: Other

Overview

Max Neeman International is a full-service Clinical Research Organization (CRO) backed by Max India's life sciences consortium. They offer a comprehensive range of clinical research services including Phase I-IV study management, data management, regulatory services, and safety monitoring, holding ISO-9000, ISO 27001, and ISO 14155 certifications.

Industry: Contract Research Organization

Partnerships

Relationships with major pharmaceutical and biotech companiesSupported 85 biotech and device firms

Beyond the preview

Go deeper on Max Neeman International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Max Neeman International.

Explore the full profile